<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Wellcome Trust - MRC Cam Stem Cell Inst</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8EBC6492-AD4B-46C0-A9BA-EBED8387812A"><gtr:id>8EBC6492-AD4B-46C0-A9BA-EBED8387812A</gtr:id><gtr:firstName>Ge</gtr:firstName><gtr:surname>Guo</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700665"><gtr:id>AAE5DDD9-E06D-4074-B629-39C2A8EEA598</gtr:id><gtr:title>A recessive genetic screens to identify regulators of embryonic stem cell self-renewal and lineage commitment</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700665</gtr:grantReference><gtr:abstractText>Embryonic stem (ES) cells exhibit indefinite growth in culture while retaining the potential to differentiate into all fetal or adult cell types. The application of ES cells in regenerative medicine requires that ES cell differentiation in culture be directed to become a specific cell type, such as dopaminergic nerve cells, which could be used to replace the damaged nerves in Parkinson?s disease patients. However, at present we are unable to reliably direct cell differentiation in this way, so even when we successfully generate nerve cells they tend to be mixed together with other unwanted types. Better understanding of the genes and molecular signaling involved in ES cell growth and differentiation in culture will help develop new culture systems for directed ES cell differentiation. Application of new techniques, such as the proposed recessive genetic screen, to the study of ES cell biology and in vitro differentiation will allow us to find novel components as well as bring new views to the established ES cell regulatory pathways.</gtr:abstractText><gtr:technicalSummary>Embryonic stem (ES) cells are pluripotent cells. They can self-renewal in culture for an indefinite time while retaining the capability of differentiating into all adult cell types. ES cells can be induced by growth factors and hormones to differentiate to many cell types in culture, opening the potential of using in vitro differentiated cells in regenerative medicine and pharmaceutical screening. However, the fundamental molecular signaling that controls ES cell self-renewal and in vitro differentiation has not been well defined. I aim to address this question using a phenotype-driven genetic screening strategy. Unbiased genetic screens can identify novel molecular components of a biological process. Recessive genetic screens have been performed in many model systems such as bacteria, yeast, fly and worm. However performing a recessive genetic screen in cultured mouse cells is limited by the diploid nature in the genome. A new tool, Blm-deficient ES cells have recently been developed in which homozygous mutations arise via highly efficient loss of heterozygosity. In my previous work, I have demonstrated the use of Blm-deficient ES cells in a genetic screen to isolate components of the DNA mismatch machinery. Here, I propose to apply this tool to identify novel molecules and pathways involved in stem cell self-renewal and in vitro differentiation.</gtr:technicalSummary><gtr:fund><gtr:end>2011-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>279872</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Stem Cell Research</gtr:department><gtr:description>establish in vitro culture of mouse epiblast stem cells</gtr:description><gtr:id>CECA19D2-9C69-4992-A3A4-821BE90BD312</gtr:id><gtr:impact>Klf4 reverts developmentally programmed restriction of ground state pluripotency.</gtr:impact><gtr:outcomeId>TfcGaFz1kTi-1</gtr:outcomeId><gtr:partnerContribution>Derive mouse Epiblast stem cells from mouse embryos</gtr:partnerContribution><gtr:piContribution>characterize and establish the mouse Epiblast stem cell lines</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Returning Carers Scheme 2013/14</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>0ACC306B-4744-4DF0-BC8D-B1F9A2985DB6</gtr:id><gtr:outcomeId>54649e3c71de34.16572606</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Expression of reprogramming factors such as Sox2, klf4, c-myc, Nanog, LIN28 and Oct4 followed by culture in a MEK inhibitor and a GSK3 inhibitor reprograms tissue cells. The invention provides new uses of these inhibitors, for example in inducing completion of the transcriptional resetting of so-called pre-pluripotent (pre-iPS) stem cells, for example as obtained from mammalian neural stem cells or epiblast stem cells treated with single or combinations of the reprogramming factors, expressed transiently or by integrative vectors. Also provided are systems for reprogramming an epiplast stem cells independently of the use of there inhibitors.</gtr:description><gtr:grantRef>G0700665</gtr:grantRef><gtr:id>D6076FE3-FEAC-4BC6-8C6D-4FD92F4B6DAF</gtr:id><gtr:impact>The use of inhibitors can improve efficiency of obtaining true pluripotent cells from somatic cells, which will have significant impacts on studying mechanism of reprogramming and the regenerative medicine.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>HW9FHx4FszG</gtr:outcomeId><gtr:patentId>WO2009101407</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>IMPROVED REPROGRAMMING OF MAMMALIAN CELLS, AND THE CELLS OBTAINED</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This vector combines a high efficient DNA transposon system Piggybac(PB) with a powerful MSCV retroviral enhancer element. Integration of the PB vector can activates nearby endogenous genes in vivo.</gtr:description><gtr:id>7676B19A-151F-4F0E-91BF-3BBDC210F40C</gtr:id><gtr:impact>This vector can be used in genetic screens in stem cells, somatic cells and in vivo.</gtr:impact><gtr:outcomeId>Y513aFopizP</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>piggybac enhancer screen vector</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A piggybac gene trap vector has been developed carring SAIRESbgeo reporter.This tool can be used in a functional screening in cultured cells and in mice.</gtr:description><gtr:id>2F59E801-8C4D-4878-BDEB-CC9ECB5B6A87</gtr:id><gtr:impact>We have used this vector in a genetic screen which identified Tcf3 as a potent ES cell self-renewal regulator</gtr:impact><gtr:outcomeId>JW84RgVgS8n</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Piggybac gene trap vector</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>mouse Epiblast stem cells are derived from post-implantation mouse embryos. They can make multiple lineages in in vitro differentiation assays, but not being capable of making chimeric mice. They are more closely related to human embryonic stem cells.</gtr:description><gtr:id>F845F209-4F83-4E18-A885-FCCA46B28972</gtr:id><gtr:impact>Research of these closely related stem cells will allow better understanding of self-renewal and pluripotency. These cell lines also can impact on research of mechanism in reprogramming.</gtr:impact><gtr:outcomeId>eUSCDCKbTBF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mouse Epiblast stem cells</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6B2F1DE7-616D-49E5-90ED-E10ABEEB5F6D</gtr:id><gtr:title>Klf4 reverts developmentally programmed restriction of ground state pluripotency.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ce0dd82b76ea1e6106225d40e4fed14"><gtr:id>6ce0dd82b76ea1e6106225d40e4fed14</gtr:id><gtr:otherNames>Guo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>cfZsxxFFb37</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>778CB2D3-78F5-4BF8-98AC-B2CB8100452F</gtr:id><gtr:title>Isolation of homozygous mutant mouse embryonic stem cells using a dual selection system.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2c84b8517fcf40edbdb86bb7a02bba1"><gtr:id>a2c84b8517fcf40edbdb86bb7a02bba1</gtr:id><gtr:otherNames>Huang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_16388_28_22127858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEC5C92A-1F7E-413E-B9AB-AEFA8FF65862</gtr:id><gtr:title>Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbc349d2fc465d67b54b7c17905208d7"><gtr:id>fbc349d2fc465d67b54b7c17905208d7</gtr:id><gtr:otherNames>Wang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>Hz11Qx6RZKB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>334890DD-A61B-473C-828A-1EE0B85F2CFE</gtr:id><gtr:title>A PiggyBac-based recessive screening method to identify pluripotency regulators.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ce0dd82b76ea1e6106225d40e4fed14"><gtr:id>6ce0dd82b76ea1e6106225d40e4fed14</gtr:id><gtr:otherNames>Guo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>DwxbLrBfCdG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6A8A415-E1D2-4483-82A6-0D3F6C80BDA5</gtr:id><gtr:title>Oct4 and LIF/Stat3 additively induce Kr&amp;uuml;ppel factors to sustain embryonic stem cell self-renewal.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>S8xBpbcdBQu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6CC1B81-8705-47AC-9C5E-0F6F7A69888A</gtr:id><gtr:title>Nanog is the gateway to the pluripotent ground state.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8150d74fc06e503692970cc227751ac"><gtr:id>a8150d74fc06e503692970cc227751ac</gtr:id><gtr:otherNames>Silva J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>ZdmTqxK1zg4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F1D6AB8-3EAB-4528-BCF4-7C60001962FC</gtr:id><gtr:title>Stat3 activation is limiting for reprogramming to ground state pluripotency.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c4df4241d0e1193d5aeffe9e19aab3d"><gtr:id>1c4df4241d0e1193d5aeffe9e19aab3d</gtr:id><gtr:otherNames>Yang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>DAJaPNzacxq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7E91576-E27B-4DF2-8D1A-83C01D8A1065</gtr:id><gtr:title>A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ce0dd82b76ea1e6106225d40e4fed14"><gtr:id>6ce0dd82b76ea1e6106225d40e4fed14</gtr:id><gtr:otherNames>Guo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>gwJvyxpZqtR</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700665</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>